News about Leinco

Finding The Right Biomarker for Cancer Research

Cancer has a major impact on society around the world and biomarkers play a pivotal role in cancer research. Leinco technologies brings you numerous resources for validating biomarkers against different cancer types and stages, discovering new biomarkers to improve diagnostics and drug development, identifying the impact biomarkers have on disease progression, and more.

Take a look at the following list of cancer types to see the associated antibodies and proteins reported in applications.

Cancer Type Related Antigens
Lung Cancer PD-L1, PD-1, CTLA-4 FAS/CD95, VEGF, EGFR
Ovarian Cancer PD-L1, PD-L2, HER-2, IGFBP-2
Breast Cancer HER-2, EGFR, p53
Colorectal Cancer VEGF, EGFR, IGFBP-2
Bladder Cancer VEGF, Survivin/BIRC5, CCL18
Kidney Cancer IL-6, VEGF, TRAIL
Pancreatic Cancer EGFR, IgG4, OPN, GDF-15
Osteosarcoma Cancer CD47, Survivin, MMP
Thyroid Cancer MMP, Galectin-3
Leukemia Cancer CTLA-4, CD52

Check the Cancer Biomarkers page for more details: Cancer Biomarkers page

Info Leinco

Manufacturer of In vivo Grade Bulk Antibodies

Leinco Technologies is a specialty manufacturer of early discovery research products including antibodies, recombinant proteins, ELISA kits, second step reagents and other life sciences products.
Leinco has developed proprietary methods for manufacturing In vivo functional grade antibodies with the highest purity standards in the industry. Their In vivo Platinum™ antibodies contain no preservatives or carrier proteins and have the most stringent quality specifications for purity (>98%), endotoxins (< 0.05 EU/mg), and aggregates.

For more information: Purified In vivo Grade Antibodies

Please use the contact us form for more information.